Recent developments surrounding Tempus AI Inc (TEM) have drawn attention, particularly due to the significant trades made by former House Speaker Nancy Pelosi. Her transactions involving major technology stocks, including Apple, Nvidia, Amazon, and Alphabet, have raised eyebrows regarding potential conflicts of interest given her lawmaker status.
Before we dive in, we have a special offer! For a limited time, you can get 70% off Stock Target Advisor’s premium features. Claim your discount here!
Stock Target Advisor’s Projection on Tempus AI:
According to Stock Target Advisor, the average analyst target price for Tempus AI Inc is USD 55.31 over the next 12 months, reflecting a Strong Buy rating. The projected price change indicates a potential increase of approximately 14.47% within a year.
Stock Target Advisor’s analysis presents a neutral stance, identifying three positive signals against three negative signals. As of the last closing price of USD 50.45, the stock has experienced fluctuations of +15.53% over the past week and +14.91% over the past month.
Analyst Ratings and Sector Coverage:
Tempus AI is covered by a total of 8 Analysts, with an average rating of Sell despite several buy recommendations. The average target price set by covering analysts is USD 55.31, with a maximum target of USD 74 and a minimum target of USD 40.
The Health Information Services sector has an average analyst rating of Strong Buy, yet Stock Target Advisor rates it as very bearish. Key players in this sector include GE HealthCare Technologies Inc., HealthEquity Inc., and Waystar Holding Corp., which are among the largest stocks contributing to overall sector performance.
Want to know more about Tempus AI? Checkout our full analysis report here, it’s free.
Conclusion:
These insights should assist investors in navigating the fluctuating market and deciding whether TEM is a suitable addition to their portfolio. Remember, investing is a strategy game, with the best outcomes for those who invest informedly and patiently.
Muzzammil is a content writer at Stock Target Advisor. He has been writing stock news and analysis at Stock Target Advisor since 2023 and has worked in the financial domain in various roles since 2020. He has previously worked on an equity research firm that analyzed companies listed on the stock markets in the U.S. and Canada and performed fundamental and qualitative analyses of management strength, business strategy, and product/services forecast as indicated by major brokers covering the stock.
